Sudarshan Pharma Industries Allots ₹96 Crore Senior Unsecured FCCBs Due 2029
Sudarshan Pharma Industries has approved the allotment of 8% senior unsecured Foreign Currency Convertible Bonds (FCCBs) worth USD 10 million, approximately ₹96 crore. This capital raise includes an option to procure an additional USD 10 million within 60 days to further bolster the company's financial position and growth initiatives.
Prism Johnson Limited Approves ₹1,750 Crore Fund Raise via Equity and Debt Issuances
Prism Johnson Limited has received board approval to raise up to ₹1,750 crore through a combination of equity-linked instruments and non-convertible debentures. The capital infusion is designed to provide the company with financial flexibility as it navigates the competitive building materials landscape.
Hind Rectifiers Board to Consider Fund Raising via Preferential Equity Issue on May 16
Hind Rectifiers Ltd has updated its upcoming board meeting agenda to include a proposal for fund raising through a preferential issue of equity shares. Scheduled for May 16, 2026, the meeting will also review the company's audited financial results for the fiscal year ended March 31, 2026, and consider a dividend recommendation.
Samvardhana Motherson Board to Evaluate Debt Fund Raise on May 20; TTM Revenue ₹1.21L Cr
Samvardhana Motherson International Limited has convened a board meeting on May 20, 2026, to discuss a proposal for raising capital through debt instruments. The company plans to evaluate the issuance of bonds and non-convertible debt securities via private placement to strengthen its financial position alongside reviewing its annual audited results.
SBI Board Approves $2 Billion Foreign Currency Fund-Raising Plan for FY 2026-27
The Executive Committee of the Central Board of State Bank of India has approved a proposal to raise up to US$ 2 billion in long-term capital during the 2026-27 financial year. This fund-raising initiative, to be executed in single or multiple tranches, is designed to bolster the bank's capital position through international debt markets.
Aviva Industries Board to Evaluate ₹350 Crore Fund Raise via Multiple Instruments
Aviva Industries has updated its board meeting agenda for May 14, 2026, to include a significant fund-raising proposal with an indicative valuation of ₹350 Crore. The company intends to explore various capital-raising avenues, including qualified institutional placements and preferential issues, to facilitate its long-term growth strategy.
Oberoi Realty Board Approves ₹4,000 Crore Fund Raise via Non-Convertible Debentures
Oberoi Realty's Board of Directors has authorized a significant capital mobilization plan involving the issuance of non-convertible debentures. The proposed fundraise of up to ₹4,000 Crore is intended to provide the liquidity required to support the developer's growth trajectory and premium project execution.
Quality Power Electrical Equipments to Consider Multi-Tranche Fund Raise on May 13
Quality Power Electrical Equipments has issued an addendum to its upcoming board meeting notice to include a proposal for raising capital. The board will meet on May 13, 2026, to discuss enabling resolutions for funds to be raised in one or more tranches. This move coincides with the scheduled declaration of the company's annual financial results.
Ujjivan Small Finance Bank Board Approves ₹2000 Crore Equity Fund Raise
The Board of Ujjivan Small Finance Bank has approved a significant capital infusion plan to raise up to ₹2000 crore through various equity issuance routes. This move is designed to strengthen the bank's Tier-I capital adequacy and support its long-term growth trajectory in the microfinance and retail banking sectors.